Xmt-1660: a phase 1b trial of a b7-h4 targeting antibody drug conjugate (adc) in endometrial, ovarian, and breast cancers
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2022)